Non-Oral Benzodiazepine Combination Feasible for Seizures in Patients With Gliomas
the ONA take:
It is feasible to treat seizures with a combination of non-oral benzodiazepines in the end-of-life phase of patients with gliomas, a new study published online ahead of print in the journal Supportive Care in Cancer has shown.
Because a rapid deterioration in neurological functioning may interfere with the oral intake of antiepileptic drugs (AEDs) for patients with gliomas who are at the end of life, researchers sought to assess the feasibility of non-oral AED treatment in an outpatient setting.
Researchers enrolled 25 patients with gliomas who had a history of epilepsy and were no longer deemed appropriate candidates for further antitumor therapy. Caregivers were to administer prophylactic treatment with buccal clonazepam as soon as swallowing difficulties developed. Acute seizures were treated with intranasal midazolam.
Results showed that seizure control was achieved in all patients and none of the patients needed to be admitted to the hospital due to recurrent seizures.
The combination of AEDs “seems to provide an important level of comfort among caregivers to be able to manage seizures at home,” the authors concluded.
It is feasible to treat seizures with a combination of non-oral benzodiazepines in the end-of-life phase of patients with gliomas.
Johan A. F. Koekkoek Affiliated withDepartment of Neurology, VU University Medical Center Department of Neurology, Medical Center Haaglanden Department of Neurology, Leiden University Medical Center Email author , Martin J. B.
- Neurotoxicity After CAR T-cell Therapy May Be Associated With Endothelial Activation
- Navigation Programs Most Effective in Increasing Follow-up Colonoscopy
- New Class of Clinical Trial Enhances Research on Cancer Care Delivery
- Specialized Interventions Reduce Aberrant Opioid Behaviors in Cancer Patients
- Nivolumab Provides Better Long-Term Efficacy Compared With Docetaxel in NSCLC
- Anticancer Properties of The Probiotic Kefir: A Review
- Navigating the Transition From Treatment to Breast Cancer Survivor
- Combining Radiation, Immunotherapy: An Emerging Challenge for Oncology Nursing
- Naldemedine Effective for Opioid-Induced Constipation in Cancer Pain
- Disruptions to Circadian Rhythm Linked to Prostate Cancer Surgery Regret
- Case Report of a KIT-mutated Melanoma Patient With an Excellent Response to Apatinib and Temozolomide Combination Therapy
- Novel Predictive Model More Effectively Identifies Risk for Lung Cancer
- Long-Term Eltrombopag Increases Platelet Counts, Decreases Bleeding in ITP
- Overall Survival Increase for Melanoma Brain Metastases
- Prophylactic Prochloperazine Ineffective for Opioid-induced Nausea/Vomiting in Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|